Cutaneous rosai-dorfman disease is a distinct clinical entity
- PMID: 12357197
- DOI: 10.1097/00000372-200210000-00001
Cutaneous rosai-dorfman disease is a distinct clinical entity
Abstract
Rosai-Dorfman disease (RDD) is a rare but distinctive clinicopathologic entity of unknown etiology affecting lymph nodes as well as extranodal sites. Although cutaneous involvement in RDD is common, purely cutaneous disease is rare and not well documented. We report 22 patients with cutaneous and superficial subcutaneous RDD. The lesions presented as papules and nodules, often with discoloration (9/22) and frequent multifocality (13/22), without predilection for a specific site of the body. Age distribution was wide and ranged from 15 to 68 years, with a median of 43.5 years. Of the 17 patients for whom information on racial background was available, 7 were Asian, 8 were white, and 2 were black, with a marked female predominance (2:1). The lesions resolved in 6 of 13 patients for whom follow-up data were available, regardless of the treatment given. Lesions persisted or recurred in 7 patients. Histologically, the lesions are invariably characterized by a proliferation of polygonal S100-positive histiocytes showing emperipolesis and a mixed inflammatory infiltrate. This study characterizes the histologic spectrum of cutaneous RDD in regard to variation in the numbers of typical S100-positive histiocytes and emperipolesis, variation in the quality and quantity of the inflammatory response, and the degree of stromal fibrosis, which resulted in a strikingly storiform growth pattern in six lesions and a lobulated pattern in two lesions. Whereas the clinical as well as histologic appearance of the cutaneous and subcutaneous lesions in the purely extranodal forms of RDD is indistinguishable from that of systemic RDD, this study emphasizes that purely cutaneous RDD is a distinct clinical entity in regard to its epidemiology and remains localized to the skin even with long-term follow-up. Patients with purely cutaneous RDD are of an older age at onset of disease (median = 43.5 years), with a reversed male/female ratio. There are no significant systemic extracutaneous or serologic manifestations. Whereas systemic RDD is commonly seen in blacks and only rarely reported in Orientals, the majority of the patients in this series with purely cutaneous RDD are Asians and whites.
Similar articles
-
[Rosai-Dorfman disease: clinicopathologic, immunohistochemical and etiologic study of 16 cases].Zhonghua Bing Li Xue Za Zhi. 2007 Jan;36(1):33-8. Zhonghua Bing Li Xue Za Zhi. 2007. PMID: 17374236 Chinese.
-
Cutaneous Rosai-Dorfman disease: clinicopathological profiles, spectrum and evolution of 21 lesions in six patients.Br J Dermatol. 2006 Feb;154(2):277-86. doi: 10.1111/j.1365-2133.2005.06917.x. Br J Dermatol. 2006. PMID: 16433797
-
Clinicopathologic characteristics of Rosai-Dorfman disease in a medical center in northern taiwan.J Formos Med Assoc. 2006 Sep;105(9):701-7. doi: 10.1016/S0929-6646(09)60197-2. J Formos Med Assoc. 2006. PMID: 16959617
-
[Clinicopathologic analysis of extranodal Rosai-Dorfman disease of breast: a report of 12 cases].Zhonghua Bing Li Xue Za Zhi. 2016 Aug 8;45(8):556-60. doi: 10.3760/cma.j.issn.0529-5807.2016.08.012. Zhonghua Bing Li Xue Za Zhi. 2016. PMID: 27510782 Review. Chinese.
-
Rosai-Dorfman disease with primary cutaneous manifestations--a case report.Ann Acad Med Singap. 1998 Jul;27(4):589-93. Ann Acad Med Singap. 1998. PMID: 9791674 Review.
Cited by
-
Panniculitis as a unique manifestation of Rosai-Dorfman disease.Postepy Dermatol Alergol. 2022 Aug;39(4):809-811. doi: 10.5114/ada.2022.118926. Epub 2022 Sep 1. Postepy Dermatol Alergol. 2022. PMID: 36090721 Free PMC article. No abstract available.
-
Histiocytic neoplasms: a brief review and differential diagnosis.J Clin Exp Hematop. 2024;64(3):156-165. doi: 10.3960/jslrt.24031. J Clin Exp Hematop. 2024. PMID: 39343608 Free PMC article. Review.
-
Rosai-Dorfman disease as a rare cause of cervical lymphadenopathy - case report and literature review.Cent Eur J Immunol. 2018;43(3):341-345. doi: 10.5114/ceji.2018.80055. Epub 2018 Oct 30. Cent Eur J Immunol. 2018. PMID: 30588179 Free PMC article. Review.
-
Rosai-Dorfman disease in the spleen of a pediatric patient: A case report.World J Clin Cases. 2021 Jul 26;9(21):6032-6040. doi: 10.12998/wjcc.v9.i21.6032. World J Clin Cases. 2021. PMID: 34368324 Free PMC article.
-
The evaluation of IgG4 and IgG expression in cutaneous Rosai-Dorfman disease.An Bras Dermatol. 2023 Sep-Oct;98(5):651-655. doi: 10.1016/j.abd.2022.07.010. Epub 2023 Jun 8. An Bras Dermatol. 2023. PMID: 37301673 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical